VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $667,000 | +139.9% | 38,566 | +265.5% | 0.03% | +57.9% |
| Q1 2016 | $278,000 | -96.6% | 10,553 | -76.8% | 0.02% | -96.1% |
| Q3 2015 | $8,116,000 | +32.6% | 45,501 | +65.2% | 0.49% | +41.3% |
| Q2 2015 | $6,120,000 | -40.4% | 27,547 | -61.6% | 0.34% | -59.1% |
| Q4 2014 | $10,270,000 | +157.4% | 71,765 | +136.0% | 0.84% | +210.3% |
| Q3 2014 | $3,990,000 | -25.8% | 30,415 | -28.7% | 0.27% | -38.5% |
| Q2 2014 | $5,379,000 | – | 42,649 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |